Publicaciones en las que colabora con Manuel Rodríguez Díaz (25)

2013

  1. Melatonin prevents dopaminergic cell loss induced by lentiviral vectors expressing A30P mutant alpha-synuclein

    Histology and Histopathology, Vol. 28, Núm. 8, pp. 999-1006

2011

  1. Terapia génica no invasiva en enfermedades neurológicas

    Revista de Neurologia, Vol. 52, Núm. 10, pp. 603-617

2009

  1. Aging effects on the dopamine transporter expression and compensatory mechanisms

    Neurobiology of Aging, Vol. 30, Núm. 6, pp. 973-986

  2. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease

    Neurobiology of Disease, Vol. 36, Núm. 3, pp. 494-508

  3. Osmosensitive response of glutamate in the substantia nigra

    Experimental Neurology, Vol. 220, Núm. 2, pp. 335-340

2008

  1. Deglycosylation and subcellular redistribution of VMAT2 in the mesostriatal system during normal aging

    Neurobiology of Aging, Vol. 29, Núm. 11, pp. 1702-1711

2007

  1. Aging of the rat mesostriatal system: Differences between the nigrostriatal and the mesolimbic compartments

    Experimental Neurology, Vol. 204, Núm. 1, pp. 147-161

  2. Nigrostriatal cell firing action on the dopamine transporter

    European Journal of Neuroscience, Vol. 25, Núm. 9, pp. 2755-2765

  3. Substantia nigra osmoregulation: Taurine and ATP involvement

    American Journal of Physiology - Cell Physiology, Vol. 292, Núm. 5

2006

  1. Glycine release in the substantia nigra: Interaction with glutamate and GABA

    Neuropharmacology, Vol. 50, Núm. 5, pp. 548-557

  2. Heterogeneous dopamine neurochemistry in the striatum: The fountain-drain matrix

    Journal of Pharmacology and Experimental Therapeutics, Vol. 319, Núm. 1, pp. 31-43

2005

  1. Glial regulation of nonsynaptic extracellular glutamate in the substania nigra

    GLIA, Vol. 49, Núm. 1, pp. 134-142

  2. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells

    European Journal of Neuroscience, Vol. 21, Núm. 7, pp. 1815-1827

2004

  1. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons

    Journal of Comparative Neurology, Vol. 479, Núm. 2, pp. 198-215

  2. Extracellular Taurine in the Substantia Nigra: Taurine-Glutamate Interaction

    Journal of Neuroscience Research, Vol. 76, Núm. 4, pp. 528-538

  3. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat

    Movement Disorders, Vol. 19, Núm. 9, pp. 1029-1042

2003

  1. Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: Different action on GABA cell subpopulations

    Movement Disorders, Vol. 18, Núm. 3, pp. 254-266

2002

  1. Response of GABAergic cells in the deep mesencephalic nucleus to dopaminergic cell degeneration: An electrophysiological and in situ hybridization study

    Neuroscience, Vol. 113, Núm. 2, pp. 311-321

2001

  1. Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons

    European Journal of Neuroscience, Vol. 13, Núm. 1, pp. 57-67

  2. Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: Similarities with cell loss in Parkinson's disease

    Experimental Neurology, Vol. 169, Núm. 1, pp. 163-181